$ULBI

Ultralife (ULBI) Q2 2026 Earnings Call Transcript

Ultralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.

Original reporting
Published Aug 8, 2026, 2:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 2:39 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ultralife (ULBI) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ULBIBullishMed
01

Why it matters

Traders can update expectations for near-term revenue capture (communications order pull-through), gross margin sustainability (tariff refund and mix), and shipment cadence for conformal wearable batteries and water-based drone platforms.

02

Market read

Record backlog and a large gross margin improvement are the headline fundamentals, with additional timing-based revenue and shipment expectations that can drive revisions to near-term estimates.

03

What to watch

Battery and Energy revenue declined due to oil and gas weakness; margin gains may depend on one-time tariff refund and favorable mix rather than fully recurring improvements.

Relevance 8/10Novelty 7/10Timing: pre-market today, following the Q2 2026 earnings call transcript

Background

Ultralife’s Q2 2026 earnings call covers segment performance (Battery and Energy, Communications Systems), backlog trends, margin drivers, and updates on product and manufacturing initiatives.

Company-level read

Ticker impact

$ULBIBullishMedium confidence
Context

Ultralife reported Q2 2026 revenue of $47.9M, record $117.5M backlog, and gross margin expansion to 28.9% on the call.

Expected impact

Bias toward upside if investors focus on backlog growth and margin trajectory; downside risk if communications revenue timing or defense/drone demand assumptions disappoint.

Evidence & confidence

The article provides multiple concrete operating metrics (revenue, EPS, backlog, gross margin, EBITDA) plus forward-looking shipment and demand expectations, which can re-rate near-term fundamentals.

Market effects

Signals improving profitability in battery and defense electronics supply chains, potentially supporting sentiment for niche defense battery suppliers.

Limited direct regional read-through; references to Raynham facility and domestic manufacturing tax credit are US-focused.

Geopolitical oil and gas sales headwind is noted, but the main incremental narrative is defense and medical wearables demand.

Counterpoint

Communications Systems growth is attributed to order timing, so near-term revenue may be volatile even with a record backlog.

Key entities

  • Ultralife Corporation

    Reported Q2 2026 results and provided backlog, margin, and forward-looking shipment and demand commentary.

  • Michael Manna

    CEO who discussed backlog pull-through and strategic execution priorities.

  • Philip A. Fain

    CFO who addressed equipment reliability and margin drivers.

Related articles

$ULBIMed

ULTRALIFE CORP (ULBI): Results of Operations and Financial Condition

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1001163.htm EXHIBIT 99.1 ex_1001163.htm Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following re

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

$GPNMed

Global Payments Q2 Earnings Call Highlights

Global Payments (NYSE:GPN) reported Q2 results and discussed its Worldpay integration and Genius point-of-sale rollout. Management guided for about 4.5% revenue growth in 2H, margins near 43%, and cited drivers including sales-force ramp and enterprise go-lives. Q2 adjusted net revenue by segment: SMB $1.51B, Enterprise $838M, Platforms $628M. Adjusted free cash flow was $687M; net leverage just below 3.5x.